Can brain tissue MSI see both neurotransmitters and lipids?

Yes. The DPI mouse-brain case showed co-imaging of neurotransmitters such as GABA, creatine, glutamine, glutamate and adenosine with various GalCer lipids.

How to interpret cholesterol increased by 205x in mouse brain?

That is the sensitivity enhancement multiple of photoionization for cholesterol, not indicating the true concentration changed by 205x; it reflects DPI's detection leap for non-polar lipids.

Why does brain imaging value matrix-free?

The brain is rich in small molecules and lipids, and matrix peaks interfere in the low-mass region; DPI and LDPI are matrix-free, allowing samples to be analyzed directly with cleaner spectra.

What is the use of LDPI at 2–3 μm for brain research?

Higher resolution can judge whether molecules localize to specific nucleus subregions or cell bands, entering single-cell/subcellular scale.

Application · Mass Spectrometry Imaging

Brain Tissue Imaging: Reading Molecular Space on Brain Sections

The brain is one of the most spatially complex organs; the functional differences among nuclei, cortex and white matter lie in molecular distribution differences. Brain tissue imaging uses mass spectrometry imaging (MSI) to acquire point by point on brain sections, presenting in-situ the spatial distribution of neurotransmitters, lipids and metabolites, moving neuroresearch from 'region naming' to 'molecular localization'.

Table of Contents
1. Entry Point of MSI in Brain Research 2. Technical Highlight: Neurotransmitter and Lipid Co-Imaging 3. Connection with Neuropharmacology and Toxicology 4. Data Interpretation and Engineering Deployment

Brain Tissue Imaging: Reading Molecular Space on Brain Sections — schematic diagram

1. Entry Point of MSI in Brain Research

In the Neo-Source MSI DPI application case, mouse brain section imaging showed simultaneous imaging of neurotransmitters (GABA, creatine, glutamine, glutamate, adenosine) and various neutral GalCer lipids, guiding neuroscience, pharmacology and neurochemistry research; both mouse coronal and transverse sections obtained comparable spatial information.

Its engineering advantages fit brain samples: matrix-free, low ion suppression, tissue analyzed directly; 20–200 μm adjustable resolution; the section remains intact after imaging for continued H&E or IHC validation.

2. Technical Highlight: Neurotransmitter and Lipid Co-Imaging

In brain tissue, neurotransmitters handle signal transmission and lipids constitute membrane structure and myelin. The DPI case shows that traditional DESI mode gives little information (choline, phosphocholine and PC lipids), while DESI/PI mode is richer, simultaneously presenting neurotransmitters and dozens of neutral GalCer lipids, with more comprehensive distribution information.

Published quantitative cases show that cholesterol signal in mouse brain increased by about 205x; this sensitivity leap from photoionization allows weakly responsive brain lipids and metabolites to be stably detected.

3. Connection with Neuropharmacology and Toxicology

Research on drug entry into brain, neurotoxicity and brain metabolism all requires molecular spatial information. MSI can present the distribution of candidate drugs and their metabolites in brain regions, and also reveal lipid/metabolic changes related to neurotoxicity. Matrix-free preparation makes such often diverse and complex sample-preparation scenarios easier to deploy.

For scenarios requiring higher spatial resolution (e.g., judging whether molecules localize to a certain cell band or nucleus subregion), the Neo-Source MSI LDPI provides 2–3 μm matrix-free ambient imaging, entering single-cell and even subcellular scale.

4. Data Interpretation and Engineering Deployment

Brain MSI still faces challenges such as tissue heterogeneity, ionization-efficiency differences and quantitative calibration; conclusions should be combined with microscopy, immunology and transcriptomic/metabolomic complements. The core value of MSI lies in providing the dimension of 'molecular space in the brain'.

DPI is engineered to be compatible with mainstream mass spectrometers from Agilent, AB SCIEX and Thermo, and provides a self-developed titanium-alloy ion transfer tube that does not damage the sample at the front end and is detachable for cleaning, enabling stable and reproducible brain tissue imaging.

Frequently Asked Questions (FAQ)

Can brain tissue MSI see both neurotransmitters and lipids?: Yes. The DPI mouse-brain case showed co-imaging of neurotransmitters such as GABA, creatine, glutamine, glutamate and adenosine with various GalCer lipids.
How to interpret cholesterol increased by 205x in mouse brain?: That is the sensitivity enhancement multiple of photoionization for cholesterol, not indicating the true concentration changed by 205x; it reflects DPI's detection leap for non-polar lipids.
Why does brain imaging value matrix-free?: The brain is rich in small molecules and lipids, and matrix peaks interfere in the low-mass region; DPI and LDPI are matrix-free, allowing samples to be analyzed directly with cleaner spectra.
What is the use of LDPI at 2–3 μm for brain research?: Higher resolution can judge whether molecules localize to specific nucleus subregions or cell bands, entering single-cell/subcellular scale.

Get Specifications & Quotation

To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).

DPI Dual-Photoionization Imaging Source Neo-Source MSI LDPI Laser Desorption Photoionization imaging ion source Lipid MSI: Drawing the 'Lipid Map' on Tissue Sections Subcellular Imaging: Reading Molecular Distribution into the 'Organelle' Scale Spatial Metabolomics MSI: Bringing Metabolomics into Real Tissue Space

← Back to MSI Ion Source Knowledge Hub